A new test for Ovarian Cancer has been approved
A new test for women with pelvic tumors which as it is known, need surgery has been approved American Food and Drug Administration (FDA). This test called OVA1 and will help doctors decide if the tumor probably is ovarian cancer and how to continue surgery.
OVA1 will identify some women who have negative consequences from ovarian cancer tests, but whose surgical cases would derive it from a gynecological oncologist’s involvement, the agency said in a news release.
Gynecological oncologists are doctors who specialize in women’s cancer, have been found to help improve survival when they perform ovarian cancer surgery, the FDA said.
The new blood test that is approved for women aged 18 and older who have pelvic masses which need a surgery is not intended to screen for ovarian cancer or replace diagnostics used to detect ovarian cancer, the FDA stressed.
OVA1 is produced by California-based Vermillion Inc., in conjunction with scientists at The Johns Hopkins University in Baltimore.
Comments
(0)